Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
© Image: Servier Deutschland GmbH

Monday, December 1, 2025

Servier Germany Launches the Information Platform “Life with Glioma” for People with Low-Grade, IDH-Mutated Gliomas

A glioma diagnosis profoundly changes the lives of patients and their families. In response to the growing need for reliable information and support, Servier Germany has launched “Life with Glioma” – a digital resource that provides trustworthy, scientifically validated information presented in an accessible way, guiding users along every step of their disease journey.

Gliomas are rare tumors of the central nervous system. Particularly for low-grade, IDH-mutated gliomas, there is a high demand for orientation and clarity: Which diagnostic steps are required? What is the role of molecular testing? And which therapeutic options are available? This new platform answers these questions in a structured and comprehensible manner, closing a significant gap in the German-speaking information landscape.

The website was developed in co-creation with a patient organization and scientifically supported by Prof. Dr. Martin Glas (Neuro-Oncology, St. Marien Hospital Lünen). His expertise focuses on the importance of molecular tumor profiling. Today, factors such as IDH status and the presence of a 1p/19q codeletion are key determinants in therapy selection and prognosis. “Life with Glioma” explains these diagnostic components clearly and demonstrates how they shape individualized treatment plans.

Website Structure and Key Content

Basic Knowledge:
The platform explains what gliomas are, which symptoms may occur, and how imaging modalities such as MRI, CT, or PET contribute to an accurate diagnosis. Clear visuals help users navigate their first medical discussions.

Diagnosis and Classification:
The WHO 2021 classification for diffuse gliomas is summarized in detail. Molecular markers such as IDH and 1p/19q are highlighted for their role in prognostic assessment and treatment planning.

Therapeutic Options:
All current treatment approaches are outlined – from “watch & wait” strategies to radiation therapy, chemotherapy, and targeted treatments for IDH-mutated tumors. TTFields, used primarily in glioblastoma, are also described.

Interdisciplinary Care Team:
The platform illustrates the collaborative approach within modern neuro-oncology: neurosurgery, oncology, psycho-oncology, physiotherapy, and other specialties work together in tumor boards to formulate personalized treatment recommendations.

Follow-Up Care and Prognosis:
Users learn how regular check-ups, rehabilitation, and continuous long-term support can help extend life while preserving quality of life.

Life with Glioma:
Practical guidance covers everyday aspects such as nutrition, exercise, work, travel, family planning, and preventive measures.

Service & Downloads:
Checklists, question guides for physician discussions, second-opinion information, a glossary, and contacts such as the German Cancer Research Center (DKFZ) and German Cancer Aid complete the offering.

Daniela Luber, Medical Advisor/Patient Engagement at Servier Germany, describes the platform’s mission: “After a brain tumor diagnosis, patients are confronted with a flood of information. With ‘Life with Glioma,’ we want to provide reliable orientation and practical support.”

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • MINTT Digital
  • 8awake
  • MINTT Digital

  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.